Inhaled RNA Therapeutics for Obstructive Airway Diseases: Recent Advances and Future Prospects

Obstructive airway diseases, e.g., chronic obstructive pulmonary disease (COPD) and asthma, represent leading causes of morbidity and mortality worldwide. However, the efficacy of currently available inhaled therapeutics is not sufficient for arresting disease progression and decreasing mortality, h...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, You, Thakur, Aneesh, Zhang, Yibang, Foged, Camilla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7912103/
https://www.ncbi.nlm.nih.gov/pubmed/33525500
http://dx.doi.org/10.3390/pharmaceutics13020177

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7912103/
https://www.ncbi.nlm.nih.gov/pubmed/33525500
http://dx.doi.org/10.3390/pharmaceutics13020177

Ejemplares similares